Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 7Phase 1/2 3Phase 1 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 13Carboplatin 13Docetaxel 11Cisplatin 11pembrolizumab 9Paclitaxel 8Gemcitabine 7Erlotinib Hydrochloride 4Bevacizumab 4anlotinib 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Gefitinib 3Dexamethasone 3dexamethasone acetate 2dexamethasone 21-phosphate 2cobimetinib 2cemiplimab 2auricularum 2atezolizumab 2apatinib 2Vemurafenib 2Surgical Procedures, Operative 2Standard of Care 2Specimen Handling 2Ramucirumab 2Calcium Dobesilate 2trametinib 1toripalimab 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma, Non-Small-Cell Lung × Fluorodeoxyglucose F18 × Clear all
NCT00002930 2013-01-18

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Memorial Sloan Kettering Cancer Center

Phase 2/3 Completed
75 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡